I had the opportunity to talk recently with a relatively advanced researcher in machine learning methods. The conversation turned briefly to the study of embeddings when he mentioned that most of his work involves things that can be embedded in Euclidean space. Since I’ve been spending a bit of time thinking about embeddings recently, I asked him some questions to get the official ML take on the subject. I was resonably gratified to learn that – although most ML engineers don’t think much about embeddings – the research on this topic considers the embedding to be tightly bound to the network architecture. It is not possible to study abstract embeddings, divorced from applications. I fully agree with this point-of-view.Continue reading “ML Embeddings and the Neuronal Code”
There are three basic business models in bioinformatics:
- A consultancy
- Licencing of insights
- Selling a tool
In the consultancy model, you are being paid for your time and expertise. The risk lies with the payer (employer) in this case. There is no guarantee that you will come up with anything useful. Therefore your margins are also low.Continue reading “Basic Business Models for Bioinformatics”
Randomised controlled trials (RCTs) have been the gold standard for statistical evidence, of treatment effect, for over 100 years. Their strength is in their attempt to avoid major sources of bias in a comparison of the evidence. However, they are costly to run, particularly in the domain of personalised medicine, to which medical AI products typically belong.Continue reading “RCTs vs Real-World Evidence for medical AI”
Just a little list inspired by a friend. 10 years of my life. A life of priviledge mixed with some pain. A lot of lessons learned, some of them more painful than they needed to be.Continue reading “2010-2019”
There is a growing awareness in the field of immunology of the potential for using mathematical techniques. The wedge-issue here is the cascade of data appearing via new cytometry techniques; large-data looks like a math issue to most people. I of course come from the other side of a spectrum – everything looks like a math issue to me – I wanted to stimulate drug development which engages with immune system dynamics by founding my company.Continue reading “Invited Speaker: Dynamics of Immune Responses”
I have a short thought, stemming from a combination of projects that I’m working on at the moment, and I want to share it.
The current trend towards Causality in AI is very attractive to people like me. It matches our personal biases and views of the world. However, it is lacking a natural heuristic. How do we decide how much resources to devote to alternative models of the world, as we gather evidence as to their accuracy?
Like I say, I have a number of parallel projects, many of which address exactly this question on technical and biological levels.
There is something from the world of business, studying entrepreneurship, which might be a better heuristic than any normative model I can come up with. Effectual entrepreneurship is a perspective on entrepreneurship, studying highly successful repeat entrepreneurs (eg. Elon Musk), which establishes control, rather than planning, at the core of entrepreneurial activities.Continue reading “Causality and the Scientific Method”
First a mea culpa, I have a huge backlog of relatively heavy articles that I really want to add to the blog. But I’ve been busy getting married – congratulations to me – and I didn’t have enough time. I strongly believe in following relatively strict guidelines on writing and editing articles, where I set myself deadlines and avoid over-writing on topics – it is just a blog after all – but for deep insights I do also have a minimum standard that I want to be able to produce before I’m willing to hit the Publish button.Continue reading “Build – Test – Move”
I am beginning a new project this week, the topic is Causal Inference. This is something I have been reading about, and wrestling with, for quite some time. Now seems a good point to take some time out, form a project, and see what I can get done on the topic.Continue reading “New Project: Causal Inference”
Today is my last official day under contract to Fosanis GmbH. I had my first encounter with the founders following my talk at the Digital Health Forum in March 2018. Following that initial meeting I became an advisor, writing a major funding proposal, bringing scientific techniques to the core of the product. In November 2018, following the closure of my own company, I became a full-time member of staff – as Head of Data Science – and led the project on the basis of the ideas contained in my funding proposal.Continue reading “Closing a Chapter @ Fosanis”
I sometimes see myself as a slow learner. I am extremely fast at deep-thinking, which somewhat disguises this fact, but I learn things from the ground up. Until I can think a topic through I sometimes feel unsure about operating from an incomplete understanding.
When I worked in academia I prefered to learn rather than to force my opinions on others. Everybody seemed reasonably smart, and they were absolutely convinced of their own correctness, and so I listened and learned. Continue reading “Why I write”